Effect of Qingdu Suppository on apoptosis of cervical cancer cells and regulation of Th1/Th2 and Th17/Treg

GENG Weihua; LOU Jiaoying; WANG Ying; YU Bibo

doi:10.3969/j.issn.2095-6606.2023.04.022

您当前的位置：

首页 >

文章列表页 >

Effect of Qingdu Suppository on apoptosis of cervical cancer cells and regulation of Th1/Th2 and Th17/Treg

TCM Clinical and Basic Studies | 更新时间：2023-08-07

- Effect of Qingdu Suppository on apoptosis of cervical cancer cells and regulation of Th1/Th2 and Th17/Treg
- Modern Chinese Clinical Medicine Vol. 30, Issue 4, Pages: 99-106(2023)
- 作者机构：
  
  1.北京中医药大学东方医院　北京　100078
  2.北京中西医结合医院
  3.北京市大兴区妇幼保健院
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.2095-6606.2023.04.022
  CLC： R285.5
- Published：30 July 2023，
  
  Received：12 April 2022，
- 稿件说明：
移动端阅览
GENG Weihua, LOU Jiaoying, WANG Ying, et al. Effect of Qingdu Suppository on apoptosis of cervical cancer cells and regulation of Th1/Th2 and Th17/Treg. [J]. Modern Chinese Clinical Medicine 30(4):99-106(2023)
DOI：

GENG Weihua, LOU Jiaoying, WANG Ying, et al. Effect of Qingdu Suppository on apoptosis of cervical cancer cells and regulation of Th1/Th2 and Th17/Treg. [J]. Modern Chinese Clinical Medicine 30(4):99-106(2023) DOI： 10.3969/j.issn.2095-6606.2023.04.022.

摘要

目的

基于细胞凋亡及免疫调控探讨清毒栓体内外抗宫颈癌的作用及机制。

方法

(1)细胞实验：将宫颈癌SiHa细胞分为5%、10%、15%、20%空白血清组；5%、10%、15%、20%含药血清组，CCK8法测定不同浓度血清对SiHa细胞活性的影响。流式细胞技术检测15%含药血清处理SiHa细胞72 h后，细胞凋亡及周期分布情况。(2)动物实验：构建宫颈癌荷瘤小鼠模型，随机数字表法将小鼠分为宫颈癌对照组(磷酸盐缓冲液灌胃)、清毒栓低剂量组(14.4 g/kg中药灌胃)、清毒栓高剂量组(28.8 g/kg中药灌胃)，每组6只，连续给药28 d，记录并计算瘤体积和体质量。分别用Ki67法和Tunel法检测3组小鼠癌组织增殖、凋亡，并用流式检测3组小鼠外周血单个核细胞中T细胞亚型表达。

结果

细胞实验表明含药血清可以抑制SiHa细胞活性，其中15%和20%含药血清处理72 h时，抑制作用最强烈，且差异无统计学意义。与15%空白血清组相比，15%含药血清组凋亡细胞增多；15%含药血清增加G0/G1期细胞，减少S期和G2/M期细胞，差异均具有统计学意义(

0.01)。动物实验表明相较于宫颈癌对照组，清毒栓组癌组织中Ki67阳性细胞比例降低、Tunel阳性细胞比例增加，且高剂量组降低或增加更明显，差异均有统计学意义(

0.01)。相较于宫颈癌对照组，清毒栓高剂量组小鼠外周血中Th1、Th17细胞比例增加，Th2、Treg细胞比例降低，Th1/Th2、Th17/Treg比例增加，差异均有统计学意义(

0.05)。

结论

清毒栓抑制SiHa细胞活性的最佳剂量是15%的含药血清，作用72 h。清毒栓可能是通过促进癌细胞凋亡，或通过免疫微环境，调控Th2向Th1漂移，抑制Treg细胞，解除免疫抑制，从而实现抑制宫颈癌。

Abstract

Objective

To investigate the effect and mechanism of Qingdu Suppository (Toxin-Clearing Suppository) on cervical cancer

in vitro

and

in vivo

based on cell apoptosis and immune regulation.

Methods

(1) Cell experiment: SiHa cells were divided into blank serum groups at various concentrations (5%

10%

15%

20%

respectively) and dosed serum groups at various concentrations (5%

10%

15%

20%

respectively). The CCK8 method was employed to investigate the effects of different serum concentrations on SiHa cell activity. Flow cytometry was then used to detect the apoptosis and cycle distribution of the cells treated with 15% dosed serum for 72 h. (2) Animal experiment: A tumor bearing mouse model of cervical cancer was established. The mice were divided into cervical cancer control group (PBS buffer gavage)

Qingdu Suppository low-dosage group (14.4 g/kg gavage) and Qingdu Suppository high-dosage group (28.8 g/kg gavage) by random number table method

with 6 mice in each group. The intervention lasted for 28 days. The tumor volume and body weight were recorded. The proliferation and apoptosis of tumor tissues in the three groups were detected via Ki67 assay and Tunel assay

respectively

and the expression of T cell subtypes in tumor tissues of the three groups were detected by flow cytometry.

Results

The cell experiment showed that the dosed serum could inhibit the activity of SiHa cells

with the 15% and 20% dosed serum exhibiting the strongest inhibitory effect when the cells were treated for 72 h

and there was no significant difference between the two groups. Compared with the 15% blank serum group

apoptotic cells increased in the 15% dosed serum group. Cells in phase G0/G1 increased and those in phase S and G2/M decreased in dosed serum

the differences were statistically significant (

0.01). The animal experiment showed that compared with the control group

the proportion of Ki67 positive cells in the tumor tissues of the two Qingdu Suppository groups decreased while Tunel positive cells increased

and the changes in the high-dosage group were more prominent with the differences being statistically significant between the two groups (

0.01). Compared with the control group

the proportion of Th1 and Th17 cells in peripheral blood of mice in the high-dosage group increased

the proportion of Th2 and Treg cells decreased

and the proportion of Th1/Th2 and Th17/Treg increased

with the differences being statistically significant (

0.05).

Conclusion

The optimal dosage of Qingdu Suppository to inhibit SiHa cell activity is 15% for 72 hours. Qingdu Suppository may inhibit cervical cancer by promoting apoptosis of cancer cells. This may also be achieved by regulating drift of Th2 to Th1

inhibiting Treg cells and relieving immunosuppression through immune microenvironment.

关键词

清毒栓宫颈癌凋亡Th1/Th2Th17/Treg

Keywords

Qingdu Suppositorycervical cancerapoptosisTh1/Th2Th17/Treg

references

COHEN P A，JHINGRAN A，OAKNIN A，et al.Cervical cancer[J].Lancet，2019,393(10167):169-182.

刘倩，王玮.浅谈宫颈癌临床治疗新进展[J].实用医学杂志，2018,34(1):5-7.

张军.宫颈癌治疗的现状及问题：从临床指南到真实世界研究[J].中国全科医学，2022,25(3):259-263.

金哲，宋爱武，李仁杰.清毒栓治疗宫颈人乳头瘤病毒感染的临床研究[J].中国中西医结合杂志，2002,22(10):735-737.

金哲，黄文玲，魏爱平.清毒栓治疗宫颈糜烂98例临床疗效观察[J].北京中医药大学学报(中医临床版)，2006,13(5):20-22.

楼姣英，金哲，李洋.中药清毒栓对宫颈癌SiHa细胞产生免疫相关细胞因子的影响[J].中国现代医生，2017,55(30):33-36,40.

楼姣英，曹颖，金哲.中药对SiHa-CTL-Treg共培养体系中CTL细胞CTLA－4、PD－1蛋白的影响[J].北京中医药大学学报，2014,37(4):227-230.

楼姣英，金哲，李云波.清毒栓血清药对宫颈癌SiHa细胞凋亡及周期的影响[J].北京中医药，2008,27(7):563-565.

金哲，李云波.清毒栓血清药理对宫颈癌SiHa细胞P53基因调控作用的研究[J].天津中医药，2007,24(1):47-50.

SMALLEY R C，PELLOM S T，MORILLON II Y M，et al. Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine[J].J Immunother Cancer，2020,8(1):1-12.

王莹. 清毒栓对宫颈癌小鼠抑瘤作用的研究及HR-HPV感染的中药用药规律探讨[D].北京：北京中医药大学，2019.

YUAN Y，CAI X，SHEN F，et al. HPV post-infection microenvironment and cervical cancer[J/OL].Cancer Lett,2021,497:243-254[2022-04-01].https://doi.org/10.1016/j.canlet.2020.10.034https://doi.org/10.1016/j.canlet.2020.10.034.

DOGAN S，TERZIOGLU E，UCAR S.Innate immune response against HPV：possible crosstalking with endocervical γδT cells[J/OL].J Reprod Immunol,2021,11(148):103435[2022-04-01].https://doi.org/10.1016/j.jri.2021.103435https://doi.org/10.1016/j.jri.2021.103435.

MATTHEWS H K，BERTOLI C，DE BRUIN R A. Cell cycle control in cancer[J]. Nat Rev Mol Cell Biol，2022,23(1):74-88.

MENS M M J，GHANBARI M. Cell cycle regulation of stem cells by microRNAs [J]. Stem Cell Rev Rep，2018,14(3):309-322.

GAO S W，LIU F. Novel insights into cell cycle regulation of cell fate determination [J]. J Zhejiang Univ-Sc B，2019,20(6):467-475.

XU X，LAI Y，HUA Z C. Apoptosis and apoptotic body: disease message and therapeutic target potentials [J]. Biosci Rep，2019,39(1):1-17.

ZHU X，ZHU J. CD4 T helper cell subsets and related human immunological disorders [J]. Int J Mol Sci，2020,21(21):1-26.

DONG C. Cytokine regulation and function in T cells [J]. Annu Rev Immunol，2021,10(39):51-76.

姜爱华，孙俊红，张芳芳，等.宫颈癌患者HPV感染状况及外周血Th1/Th2细胞因子变化研究[J].实用癌症杂志，2021,36(4):555-558.

LIN W，NIU Z，ZHANG H，et al. Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer [J]. IJCEP，2019,12(9):3604-3612.

凡芳，朱艺欣，左泳泳，等.吉西他滨联合表柔比星对宫颈癌患者的疗效及血清Th1/Th2细胞因子水平的影响[J].检验医学与临床，2021,18(20):2961-2963,2966.

邵雪艳.西黄丸联合新辅助化疗对晚期宫颈癌患者预后及Th1/Th2细胞因子的影响[J].中国合理用药探索，2020,17(6):92-96.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

益气解毒方对γ射线致小鼠小肠急性损伤的防护效应研究

消瘤方对子宫内膜异位症患者子宫内膜细胞增殖和凋亡的影响

Related Author

李盼飞

卢曦

王安

王磊

王艳

石中玉

高誉姗

刘珍清

Related Institution

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine

Department of Gynecology of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

⁰